Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186665 · ClinicalTrials.gov registry record · Phase 4
Plaque Psoriasis Study in Pediatric Subjects
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT02186665 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 19 participants.
The verdict
NCT02186665, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.
Interventions
- DRUG placebo comparator
- DRUG calcitriol ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02186665
The ClinicalTrials.gov registry entry for NCT02186665 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo comparator is the first listed.
NCT02186665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02186665 about?
NCT02186665 is a clinical study titled "Plaque Psoriasis Study in Pediatric Subjects". The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.
What is the current status of trial NCT02186665?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2014-07. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02186665?
The interventions under investigation include: placebo comparator (DRUG), calcitriol ointment (DRUG).
Who is sponsoring clinical trial NCT02186665?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.